Primary Endpoint

The main result that is measured at the end of a study to see if a given treatment worked (e.g., the number of deaths or the difference in survival… (More)

Topic mentions per year

Topic mentions per year

1967-2017
050019672017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
BACKGROUND Cell salvage is commonly used as part of a blood conservation strategy. However concerns among clinicians exist about… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2015
Highly Cited
2015
BACKGROUND Nivolumab, a fully human IgG4 PD-1 immune checkpoint inhibitor antibody, can result in durable responses in patients… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2013
Highly Cited
2013
BACKGROUND CLEOPATRA is a phase 3 study to compare the efficacy and safety of pertuzumab, trastuzumab, and docetaxel with placebo… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2012
Highly Cited
2012
BACKGROUND Erlotinib has been shown to improve progression-free survival compared with chemotherapy when given as first-line… (More)
Is this relevant?
Highly Cited
2012
Highly Cited
2012
BACKGROUND In view of evidence that statin therapy increases risk of diabetes, the balance of benefit and risk of these drugs in… (More)
Is this relevant?
Highly Cited
2012
Highly Cited
2012
OBJECTIVES This study sought to assess the impact of targeted left ventricular (LV) lead placement on outcomes of cardiac… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 3
  • figure 4
Is this relevant?
Highly Cited
2011
Highly Cited
2011
OBJECTIVES The purpose of the study was to systematically evaluate the significance of platelet reactivity on clopidogrel… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
OBJECTIVES This is the first of a pair of studies designed to assess efficacy, safety and tolerability of onabotulinumtoxinA… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND Renal transplant recipients are at increased risk of premature cardiovascular disease. Although statins reduce… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
1997
Highly Cited
1997
  • Lancet
  • 1997
BACKGROUND Platelet aggregation is a dominant feature in the pathophysiology of unstable angina. Percutaneous transluminal… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?